The company launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate Covid-19 at a price of about Rs 103 per tablet.
from Latest News https://ift.tt/2zVp6w4
Sunday, 21 June 2020
Glenmark Pharma gains 15% on launch of Favipiravir, a potential Covid drug
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment